Low-grade adenosquamous carcinoma of the breast-A case report with a BRCA1 germline mutation

Pathology Research and Practice

Volumn 206, Issue 7, 2010, Pages 511-513

  Nol, Jean Christophe ^a   Buxant, Frédéric ^a   Engohan Aloghe, Corinne ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

BRCA1; Breast; Immunohistochemistry; Low grade adenosquamous carcinoma; Pathology

Indexed keywords

BRCA1 PROTEIN; CYTOKERATIN 5; CYTOKERATIN 6; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; KI 67 ANTIGEN; ONCOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN CERB2; PROTEIN P63; UNCLASSIFIED DRUG; TUMOR MARKER;

ADENOSQUAMOUS CARCINOMA; ADULT; ANAMNESIS; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER GRADING; CANCER SURGERY; CASE REPORT; ECHOGRAPHY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GERMLINE MUTATION; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR VOLUME; BREAST TUMOR; GENETICS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; SECOND CANCER; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; TUMOR MARKERS, BIOLOGICAL;

EID: 77954035885     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.01.008     Document Type: Article

References (15)

1. Bellino R., Arisio R., D'Addato F., et al. Metaplastic breast carcinoma: pathology and clinical outcome. Anticancer Res. 2003, 23(1B):669-673.
2. Breuer A., Kandel M., Fisseler-Eckhoff A., et al. BRCA1 germline mutation in a woman with metaplastic cell breast cancer. Onkologie 2007, 30(6):316-318.
3. Drudis T., Arroyo C., Van Hoeven K., Cordon-Cardo C., Rosen P.P. The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study. Pathol. Annu. 1994, 29(Pt 2):181-197.
4. Ho B.C.-S., Tan H.W., VK-M Lee, Tan PH Preoperative and intraoperative diagnosis of low-grade adenosquamous carcinoma of the breast: potential diagnostic pitfalls. Histopathology 2006, 49:603-611.
5. Kinkor Z., Skalova A., Michal M., Janousek M., Kheck M. Metastasing and relapsing "low grade" adenosquamous metaplastic breast cancer-is there a really indolent lesion? A description of three cases and review of literature. Ceska Gynekol. 2005, 70(3):211-216. (abstract).
6. McCarthy A., Savage K., Gabriel A., Naceur C., Reis-Filho J.S., Ashworth A. A mouse model of basal-like breast carcinoma with metaplastic elements. J. Pathol. 2007, 211:389-398.
7. Reis-Filho J.S., ANJ Tutt Triple negative tumours: a critical review. Histopathology 2008, 52:108-118. 10.1111/j.1365-2559.2007.02889.x.
8. Rosen P.P., Ernsberger D. Low-grade adenosquamous carcinoma. A variant of metaplastic mammary carcinoma. Am. J. Surg. Pathol. 1997, 11:351-358.
9. Y. Sasaki, H. Tsuda Clinicopathological characteristics of triple-negative breast cancers, Breast Cancer doi:10.1007/s12282-009-0153-5.
10. E.N. Supitsin, A.P. Sokolenko, D.A. Voskresenskiy et al. Mixed epithelial/mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast in BRCA1 carrier. Breast Cancer doi:10.1007/s12282-009-0105-0.
11. Tavassoli F.A., Devilee P. World Health Organization Classification of Tumours.Pathology and Genetics. Tumours of the Breast and Female Genital Organs 2003, IARC Press, Lyon.
12. Tse G.M., Tan P.H., Putti T.C., Lui P.C.W., Chaiwun B., BKB Law Metaplastic carcinoma of the breast: a clinicopathological review. J. Clin. Pathol. 2006, 59:1079-1083.
13. Turner N.C., Reis-Filho J.S. Basal-like breast cancer and the BRCA1 phenotype. Oncogene 2006, 25:5846-5853.
14. Van Hoeven K.H., Drudis T., Cranor M.L., Erlandson R.A., Rosen P.P. Low-grade adenosquamous carcinoma of the breast. A clinicopathologic study of 32 cases with ultrastructural analysis. Am. J. Surg. Pathol. 1993, 17(3):248-258.
15. Yap T.A., Boss D.S., Fong P.C., et al. First in human phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of KU-0059436 (Ku), a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in cancer patients (p), including BRCA1/2 mutation carriers. J. Clin. Oncol. 2007, 25:3529. (abstract).